Pathological aspects of spontaneous uveitis and retinopathy in HLA-A29 transgenic mice and in animal models of retinal autoimmunity: Relevance to human pathologies

被引:12
作者
de Kozak, Yvonne [2 ,3 ,4 ]
Camelo, Serge [2 ,3 ,4 ]
Pla, Marika [1 ]
机构
[1] Hop St Louis, Inst Univ Hematol, Dept Bioexperimentat, Paris, France
[2] Univ Paris 06, UMRS 872, Ctr Rech Cordeliers, FR-75270 Paris, France
[3] Univ Paris 05, UMRS 872, Paris, France
[4] Inst Natl Sante & Rech Med U872, Paris, France
关键词
HLA-A29; transgenic mice; retina; melanin; experimental autoimmune uveoretinitis; birdshot retinochoroidopathy; Vogt-Koyanagi-Harada; autoimmune;
D O I
10.1159/000119872
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: A major increased risk of developing birdshot chorioretinopathy is reported in humans who are HLA-A29-positive. To better characterize this disease, an animal model of HLA-A29-associated disease was developed and the pathology arising spontaneously in these transgenic mice was compared to animal models of autoimmune uveoretinitis and to human pathology. Materials and Methods: HLA-A2902 cDNA (A29c) was obtained from a patient suffering from birdshot retinochoroidopathy and used for transgene construct to generate HLA-A29 transgenic mice. Histopathological examination of the animal cohort was performed up to 15 months of age. It was compared with the ocular pathology developed in C57BL/6 mice and in Lewis rats immunized with retinal autoantigens. Results: Aging HLA-A29 transgenic mice spontaneously developed an ocular disease with resemblance to experimental retinal-Ag-induced autoimmune ocular disease and to human pathologies shown in birdshot retinochoroidopathy, Vogt-Koyanagi-Harada and sympathetic ophthalmia. Pathogenic mechanisms could possibly be shared by these conditions. Conclusion: Humanized models of ocular inflammation developed in HLA class I and class II transgenic mice will help better understand the mechanisms responsible for ocular inflammation. Local control of autoimmunity in HLA-A29-positive individuals would be an important option for new therapeutic strategies. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 28 条
[1]  
Agarwal RK, 2004, METH MOLEC MED, V102, P395
[2]   EXPERIMENTAL AUTOIMMUNE UVEORETINITIS IN MICE - INDUCTION BY A SINGLE ELICITING EVENT AND DEPENDENCE ON QUANTITATIVE PARAMETERS OF IMMUNIZATION [J].
CASPI, RR ;
CHAN, CC ;
LEAKE, WC ;
HIGUCHI, M ;
WIGGERT, B ;
CHADER, GJ .
JOURNAL OF AUTOIMMUNITY, 1990, 3 (03) :237-246
[3]  
CASPI RR, 1988, J IMMUNOL, V140, P1490
[4]  
CASPI RR, 1992, J IMMUNOL, V148, P2384
[5]   Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis [J].
de Kozak, Y ;
Andrieux, K ;
Villarroya, H ;
Klein, C ;
Thillaye-Goldenberg, B ;
Naud, MC ;
Garcia, E ;
Couvreur, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (12) :3702-3712
[6]   S-ANTIGEN-INDUCED EXPERIMENTAL AUTOIMMUNE UVEO-RETINITIS IN RATS [J].
DEKOZAK, Y ;
SAKAI, J ;
THILLAYE, B ;
FAURE, JP .
CURRENT EYE RESEARCH, 1981, 1 (06) :327-337
[7]   EVIDENCE FOR IMMEDIATE HYPERSENSITIVITY PHENOMENA IN EXPERIMENTAL AUTOIMMUNE UVEORETINITIS [J].
DEKOZAK, Y ;
SAINTELAUDY, J ;
BENVENISTE, J ;
FAURE, JP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (08) :612-617
[8]  
HIROSE S, 1989, CLIN EXP IMMUNOL, V77, P106
[9]  
Horie Y, 2006, MOL VIS, V12, P1601
[10]  
Klein J, 2000, NEW ENGL J MED, V343, P1504